Paper7350435
Oral hydralazine therapy for primary pulmonary hypertension.
Rubin LJ and 1 other. N Engl J Med, 1980. Cited by 248 papers, by iCite.
Cite this record
ConductScience Library. Oral hydralazine therapy for primary pulmonary hypertension. Papers, record 7350435. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7350435
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hydralazine | Major topic |
| Hypertension, Pulmonary | Major topic |
| Administration, Oral | |
| Adult | |
| Blood Pressure | |
| Cardiac Catheterization | |
| Cardiac Output | |
| Female | |
| Heart Rate | |
| Hemodynamics | |
| Humans | |
| Male | |
| Middle Aged | |
| Oxygen | |
| Oxygen Consumption | |
| Physical Exertion | |
| Vascular Resistance |
Source PubMed
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 248 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40013009 | How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension. | Pulm Circ | 2025 | https://conductscience.org/library/papers/40013009 | PubMed |
| 39980709 | Introducing Historical Vignettes in Pulmonary Circulation. | Pulm Circ | 2025 | https://conductscience.org/library/papers/39980709 | PubMed |
| 39906119 | Pulmonary Hypertension: A Personal Journey. | Pulm Circ | 2025 | https://conductscience.org/library/papers/39906119 | PubMed |
| 34422153 | Pulmonary Vascular Response Patterns to Exercise: Is there a Role for Pulmonary Arterial Pressure Assessment during Exercise in the Post-Dana Point Era? | Adv Pulm Hypertens | 2010 | https://conductscience.org/library/papers/34422153 | PubMed |
| 32180938 | Pulmonary vasodilation in acute pulmonary embolism - a systematic review. | Pulm Circ | 2020 | https://conductscience.org/library/papers/32180938 | PubMed |
| 28632001 | Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis. | Pulm Circ | 2017 | https://conductscience.org/library/papers/28632001 | PubMed |
| 22974762 | Iron chelation inhibits the development of pulmonary vascular remodeling. | Free Radic Biol Med | 2012 | https://conductscience.org/library/papers/22974762 | PubMed |
| 7451649 | Influence of prostaglandin synthesis inhibitors on pulmonary vasodilatory effects of hydralazine in dogs with hypoxic pulmonary vasoconstriction. | J Clin Invest | 1981 | https://conductscience.org/library/papers/7451649 | PubMed |
| 7442300 | Primary pulmonary hypertension: modern approaches to an old problem. | Lung | 1980 | https://conductscience.org/library/papers/7442300 | PubMed |
| 7442081 | [Comparison of oral diazoxide and minoxidil in refractory hypertension]. | Klin Wochenschr | 1980 | https://conductscience.org/library/papers/7442081 | PubMed |
| 7272141 | Primary pulmonary hypertension: effects of nifedipine. | Br Heart J | 1981 | https://conductscience.org/library/papers/7272141 | PubMed |
| 7188437 | Corticosteroid responsive pulmonary hypertension in systemic lupus erythematosus. | Clin Rheumatol | 1982 | https://conductscience.org/library/papers/7188437 | PubMed |
| 7128637 | Hemodynamic effects of sodium nitroprusside in patients with ventricular septal defect. | Eur J Pediatr | 1982 | https://conductscience.org/library/papers/7128637 | PubMed |
| 7107172 | Vasodilator therapy of pulmonary hypertension in the CRST syndrome. | Ir J Med Sci | 1982 | https://conductscience.org/library/papers/7107172 | PubMed |
| 7022422 | Effects of captopril (SQ 14,225) in a patient with primary pulmonary hypertension. | Postgrad Med J | 1981 | https://conductscience.org/library/papers/7022422 | PubMed |
| 6821608 | Ambulatory monitoring of pulmonary artery pressure. A preliminary clinical evaluation. | Br Heart J | 1983 | https://conductscience.org/library/papers/6821608 | PubMed |
| 6786460 | Remission of primary pulmonary hypertension during treatment with diazoxide. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6786460 | PubMed |
| 6782123 | Pulmonary vasodilator responses to nitroprusside and nitroglycerin in the dog. | J Clin Invest | 1981 | https://conductscience.org/library/papers/6782123 | PubMed |
| 6743418 | Detrimental effects of verapamil in patients with primary pulmonary hypertension. | Br Heart J | 1984 | https://conductscience.org/library/papers/6743418 | PubMed |
| 6704262 | Continuous recording of pulmonary artery pressure in unrestricted subjects. | Br Heart J | 1984 | https://conductscience.org/library/papers/6704262 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7350435
GET https://conductscience.org/api/papers/v1/7350435/cited_by?page=2